Device Trial Radar · NCT00042549
Lithotripsy for the Treatment of Gallstones
Last checked: Nov 20, 2026Latest source record: Jun 24, 2005 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
184
Actual
Start
May 2002
Primary completion
Not stated
Sponsor
- Lead sponsor
- Medstone InternationalNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 5, 2002
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 90 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the effectiveness and safety of using the Medstone lithotripter to treat single non-calcified gallstones from 4 to 20 mm in diameter.
Conditions
- Cholelithiasis
Interventions
Extracorporeal Shock Wave LithotripsyDevice
ursodiolDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
The Methodist Hospital
Houston, Texas
Virgina Commonwealth University
Richmond, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.